Dr Reddy’s Accelerates Vaccine Efforts

Pfizer CEO Offers Vaccine Update; Cipla Launches Antibody Test

Dr Reddy’s is collaborating with the Indian government’s biotechnology department to conduct Sputnik V vaccine clinical trials In India, after it received approval from the DCGI. Pfizer’s CEO has offered an update on the development and distribution of the COVID-19 vaccine that it is developing in partnership with BioNTech. Cipla has launched COVID-19 antibody detection kits for India. And the WHO has called for management of the coronavirus “infodemic.”

Umbrella
Dr Reddy’s, Pfizer and Cipla work towards mitigating the impact of the pandemic • Source: Shutterstock

Dr Reddy’s Laboratories has partnered with the Biotechnology Industry Research Assistance Council (BIRAC), of the Indian government’s department of biotechnology, “to accelerate our efforts” in bringing the Sputnik V COVID vaccine to India.

Satish Reddy, chairman of Dr Reddy’s, said “we are pleased with the collaboration with BIRAC as an advisory partner for...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

Nexus Faces Five Year Wait On Injectable Minocycline

Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains

test

uygukgigo

 
• By 

More from Business

uygukgigo

 
• By 

Test

Podcast test

 
• By